|
gptkbp:instanceOf
|
gptkb:chemical_compound
recreational drug
GABA_A receptor agonist
|
|
gptkbp:actsOn
|
gptkb:GABA_A_receptor
|
|
gptkbp:CASNumber
|
2763-96-4
|
|
gptkbp:category
|
gptkb:Dragon
gptkb:isoxazole
mycotoxin
|
|
gptkbp:chemicalFormula
|
C4H6N2O2
|
|
gptkbp:color
|
white
|
|
gptkbp:discoveredBy
|
gptkb:Oskar_Wintersteiner
|
|
gptkbp:discoveredIn
|
1965
|
|
gptkbp:effect
|
delirium
muscle relaxation
dissociation
sedation
euphoria
ataxia
hallucinations
|
|
gptkbp:foundIn
|
gptkb:Amanita_muscaria
gptkb:Amanita_pantherina
|
|
gptkbp:hasInChIKey
|
YMIYQPMQYVGBLN-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
NCc1onc(C)=O
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
muscimol
|
|
gptkbp:IUPACName
|
5-(aminomethyl)-1,2-oxazol-3(2H)-one
|
|
gptkbp:legalStatus
|
unscheduled (most countries)
|
|
gptkbp:mechanismOfAction
|
GABA_A receptor agonist
|
|
gptkbp:meltingPoint
|
185–195 °C
|
|
gptkbp:metabolism
|
gptkb:ibotenic_acid
|
|
gptkbp:molecularWeight
|
114.10 g/mol
|
|
gptkbp:origin
|
natural
|
|
gptkbp:PubChem_CID
|
5326
CHEBI:7035
CHEMBL504
|
|
gptkbp:relatedTo
|
gptkb:ibotenic_acid
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
intraperitoneal
|
|
gptkbp:solubility
|
water-soluble
|
|
gptkbp:studiedBy
|
gptkb:pharmacy
neuroscience
|
|
gptkbp:toxicity
|
moderate
|
|
gptkbp:UNII
|
6U6X5RYE5Z
|
|
gptkbp:bfsParent
|
gptkb:Fungi
|
|
gptkbp:bfsLayer
|
4
|